Roche Holding AG (OTCMKTS:RHHBY) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) have earned an average recommendation of "Moderate Buy" from the seven ratings firms that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, one has given a buy recommendation and two have given a strong buy recommendation to the company.

A number of research firms have recently issued reports on RHHBY. HSBC lowered Roche from a "buy" rating to a "hold" rating in a research note on Monday, April 28th. Hsbc Global Res lowered shares of Roche from a "strong-buy" rating to a "hold" rating in a research note on Monday, April 28th.

Roche Stock Down 1.8%

Roche stock traded down $0.72 during trading on Tuesday, reaching $38.90. 2,227,212 shares of the company's stock were exchanged, compared to its average volume of 2,649,661. The company's 50-day moving average is $39.73 and its two-hundred day moving average is $39.14. The company has a quick ratio of 1.20, a current ratio of 1.48 and a debt-to-equity ratio of 0.85. Roche has a 52-week low of $33.76 and a 52-week high of $44.31.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. GAMMA Investing LLC increased its holdings in Roche by 6,463.8% during the 1st quarter. GAMMA Investing LLC now owns 528,778 shares of the company's stock worth $21,759,000 after purchasing an additional 520,722 shares during the last quarter. Boston Common Asset Management LLC grew its position in shares of Roche by 10.0% during the first quarter. Boston Common Asset Management LLC now owns 325,732 shares of the company's stock worth $13,369,000 after buying an additional 29,522 shares in the last quarter. Altrius Capital Management Inc increased its stake in shares of Roche by 3.6% in the first quarter. Altrius Capital Management Inc now owns 189,993 shares of the company's stock worth $7,818,000 after buying an additional 6,545 shares during the last quarter. Bard Financial Services Inc. raised its holdings in Roche by 25.3% in the first quarter. Bard Financial Services Inc. now owns 138,900 shares of the company's stock valued at $5,716,000 after acquiring an additional 28,050 shares in the last quarter. Finally, Rhumbline Advisers boosted its stake in Roche by 7.4% during the 1st quarter. Rhumbline Advisers now owns 107,252 shares of the company's stock valued at $4,413,000 after acquiring an additional 7,374 shares during the last quarter.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.